Surrozen, Inc.
SRZN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001824893
In the last 90 days, Surrozen, Inc. insiders filed 0 open-market purchases and 1 sale; 70 institutions reported holding it in 13F filings for Q2 2026, worth $314.5M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Surrozen, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- +5 vs. Q2 2025
- Shares held
- 6.34M
- +313.2K (+5.2%) vs. Q2 2025
- Total value
- $81.7M
- +$27.8M (+51.6%) vs. Q2 2025
- New holders
- 9
- 6 more added
- Sold out
- 4
- 3 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SRZN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 70 | $314.5M |
| Q1 2026 | 59 | $314.2M |
| Q4 2025 | 55 | $195.1M |
| Q3 2025 | 36 | $81.7M |
| Q2 2025 | 31 | $53.9M |
| Q1 2025 | 30 | $63.5M |
| Q4 2024 | 24 | $35.4M |
| Q3 2024 | 23 | $25.5M |
| Q2 2024 | 21 | $23.1M |
| Q1 2024 | 16 | $15.0M |
| Q4 2023 | 17 | $9.78M |
| Q3 2023 | 25 | $7.90M |
| Q2 2023 | 22 | $8.62M |
| Q1 2023 | 23 | $9.91M |
| Q4 2022 | 26 | $9.36M |
| Q3 2022 | 27 | $44.1M |
| Q2 2022 | 24 | $63.1M |
| Q1 2022 | 30 | $67.4M |
| Q4 2021 | 32 | $153.5M |
| Q3 2021 | 29 | $150.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Surrozen, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| The Column Group LLC | 1,499,773 | $19.3M | 23.88% | 00.0% | Unchanged |
| StemPoint Capital LP | 713,463 | $9.19M | 1.85% | +26,924+3.9% | Added |
| VR Adviser, LLC | 632,931 | $8.16M | 0.46% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 602,626 | $7.76M | 0.10% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 310,000 | $3.99M | 1.46% | 00.0% | Unchanged |
| Vanguard Group Inc | 266,418 | $3.43M | 0.00% | +47,468+21.7% | Added |
| Vivo Capital, LLC | 260,000 | $3.35M | 0.27% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 250,146 | $3.22M | 2.62% | −55,883−18.3% | Reduced |
| Samsara BioCapital, LLC | 241,400 | $3.11M | 0.41% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 229,527 | $2.96M | 0.18% | 00.0% | Unchanged |
| Acuta Capital Partners, LLC | 178,415 | $2.30M | 2.38% | +8,415+5.0% | Added |
| Braidwell LP | 140,000 | $1.80M | 0.05% | 00.0% | Unchanged |
| Regents of the University of California | 133,207 | $1.72M | 0.09% | 00.0% | Unchanged |
| Millennium Management LLC | 109,769 | $1.41M | 0.00% | +109,769 | New |
| Adage Capital Partners GP, L.L.C. | 88,653 | $1.14M | 0.00% | 00.0% | Unchanged |
| Euclidean Capital LLC | 87,696 | $1.13M | 0.47% | 00.0% | Unchanged |
| Eversept Partners, LP | 76,997 | $992.1K | 0.08% | +76,997 | New |
| Balyasny Asset Management LLC | 70,732 | $911.4K | 0.00% | +70,732 | New |
| Schonfeld Strategic Advisors LLC | 69,024 | $889.4K | 0.01% | +69,024 | New |
| ArrowMark Colorado Holdings LLC | 55,123 | $710.3K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 54,527 | $702.9K | 0.00% | +23,564+76.1% | Added |
| Board of Trustees of The Leland Stanford Junior University | 52,130 | $671.7K | 0.08% | 00.0% | Unchanged |
| Woodline Partners LP | 48,193 | $621.0K | 0.00% | +48,193 | New |
| Trustees of Columbia University in the City of New York | 47,930 | $617.6K | 0.09% | 00.0% | Unchanged |
| Morgan Stanley | 34,764 | $447.9K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 21,715 | $280.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 14,726 | $189.7K | 0.00% | +100+0.7% | Added |
| Citadel Advisors LLC | 13,875 | $178.8K | 0.00% | +3,424+32.8% | Added |
| BlackRock, Inc. | 13,743 | $177.1K | 0.00% | −1,740−11.2% | Reduced |
| State Street Corp | 13,326 | $171.7K | 0.00% | +13,326 | New |
| Alyeska Investment Group, L.P. | 10,188 | $131.3K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 1,000 | $12.9K | 0.00% | +1,000 | New |
| Wolverine Asset Management LLC | 281 | $3.62K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 13 | $168 | 0.00% | +13 | New |
| Bank of America Corp | 6 | $77 | 0.00% | −46−88.5% | Reduced |
| SBI Securities Co., Ltd. | 2 | $26 | 0.00% | +2 | New |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −67,566−100.0% | Sold out |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −259−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −216−100.0% | Sold out |